Form 4: Five Below Director Sells Shares Under 10b5-1 Plan

Five Below Director Kathleen S. Barclay sold 2,200 shares of common stock at a weighted average price of $182.03 as part of a pre-arranged 10b5-1 trading plan.

Summary

• Kathleen S. Barclay, a Director of Five Below, Inc. (FIVE), reported the sale of 2,200 shares of common stock.
• The transaction occurred on December 15, 2025, at a weighted average price of $182.03 per share.
• The shares were sold in multiple transactions within a price range of $182.02 to $182.11.
• This sale was executed pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.
• Following this transaction, Kathleen S. Barclay beneficially owns 9,214 shares of Five Below common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While an insider sale can sometimes be viewed negatively, the explicit mention of a Rule 10b5-1 plan indicates a pre-scheduled transaction, which typically mitigates concerns about the insider acting on new, non-public information. It's a routine part of executive compensation and financial planning.

Negatives

• A director's sale of company stock, even if pre-planned, can sometimes be perceived as a lack of confidence by some investors, although the 10b5-1 plan mitigates this concern.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: May observe a minor, neutral impact on sentiment due to a director's planned sale, which is generally not indicative of a change in company fundamentals.

Key Dates

Recommendation

The sale by Director Kathleen S. Barclay was executed under a pre-arranged Rule 10b5-1 trading plan. Such planned sales are common for executives and directors for personal financial management and do not typically signal a change in the company's fundamental outlook or performance. Therefore, this specific transaction alone does not warrant a change in investment recommendation, and a 'hold' stance is appropriate, pending further fundamental analysis of Five Below's business.

Keywords

Five Below, FIVE, Kathleen S. Barclay, Insider Sale, Form 4, Director Transaction, Equity Sale, 10b5-1 Plan